Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 20 Prostatic Neoplasms 19 Glioblastoma 18 Breast Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 15 Lung Neoplasms 12 Rectal Neoplasms 11 Oropharyngeal Neoplasms 10 Neoplasms 9 Head and Neck Neoplasms 8 Glioma 8 Astrocytoma 8 Neoplasm Metastasis 7 Sarcoma 6 Esophageal Neoplasms 6 Carcinoma, Squamous Cell 6 Urinary Bladder Neoplasms 5 Triple Negative Breast Neoplasms 5 Lymphoma, Follicular 5 Hodgkin Disease 5 Gliosarcoma 5 Esophageal Squamous Cell Carcinoma 5 Carcinoma 5 Burkitt Lymphoma 5 Brain Neoplasms 5 Adenocarcinoma of Lung 5 Adenocarcinoma Of Esophagus 5 Small Cell Lung Carcinoma 4 Pancreatic Neoplasms 4 Nasopharyngeal Carcinoma 4

Interventions

atezolizumab 1 Sodium Chloride 1 Radiotherapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Advanced Cervical Cancer × Radiotherapy × 90 days × Clear all

NCT03612791 2026-04-03

ATEZOLACC

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Completed

Locally Advanced Cervical Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡